Antihistamine shows promise for MS eye disorder in Early-Ended trial
Disease control
Terminated
This study tested whether clemastine fumarate, an antihistamine, could improve eye movement in people with multiple sclerosis (MS) who have a specific eye coordination problem called internuclear ophthalmoparesis (INO). The trial planned to enroll 80 adults with MS and INO, givin…
Phase: PHASE3 • Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated May 15, 2026 11:55 UTC